HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Barber, G. N. Articles by Lloyd, G. Search for Related Content PubMed PubMed Citation Articles by Barber, G. N. Articles by Lloyd, G. Agricola Articles by Barber, G. N. Articles by Lloyd, G.

Expression of the Lassa Virus Nucleocapsid Protein in Insect Cells Infected With a Recombinant Baculovirus: Application to Diagnostic Assays for Lassa Virus Infection

G. N. Barber

Pathology Division, Public Health Laboratory Service, Centre for Applied Microbiology and Research, Porton Down, Salisbury SP4 0JG, U.K.

The coding region of the gene for the nucleocapsid protein of Lassa virus has been inserted into the genome of Autographa californica nuclear polyhedrosis virus (AcNPV) using the transfer vector pAcYM1, so that expression of the foreign DNA is under the control of the promoter of the AcNPV polyhedrin gene. Infection of cultured Spodoptera frugiperda cells with recombinant virus resulted in the synthesis of high levels of a protein that was indistinguishable from the authentic Lassa virus protein by SDS gel electrophoresis and immunoblotting with a variety of specific immune sera and monoclonal antibodies (MAbs). The kinetics of appearance of the protein were comparable to those of polyhedrin production in wild-type AcNPV-infected cells. The recombinant material was antigenic when used in ELISA for Lassa virus-specific antibodies, reacting well with MAbs specific for the nucleocapsid protein and with sera from experimentally infected guinea-pigs. The recombinant ELISA was able to clearly distinguish sera from human cases of Lassa fever against a panel of known negative sera of African origin. Recombinant-infected insect cells were an effective substitute for mammalian cells infected with Lassa virus itself in the immunofluorescence assay for Lassa virus-specific antibodies. This system offers attractive alternatives to the use of Lassa virus-infected materials as reagents in diagnostic procedures.

Present address: Regional Primate Research Center, I-421 Health Sciences Building, University of Washington, Seattle, Washington 98195, U.S.A.

Received 28 June 1989; accepted 26 September 1989.

This article has been cited by other articles:

				M. Saijo, M.-C. Georges-Courbot, P. Marianneau, V. Romanowski, S. Fukushi, T. Mizutani, A.-J. Georges, T. Kurata, I. Kurane, and S. Morikawa Development of Recombinant Nucleoprotein-Based Diagnostic Systems for Lassa Fever Clin. Vaccine Immunol., September 1, 2007; 14(9): 1182 - 1189. [Abstract] [Full Text] [PDF]

				J. ter Meulen, K. Koulemou, T. Wittekindt, K. Windisch, S. Strigl, S. Conde, and H. Schmitz Detection of Lassa Virus Antinucleoprotein Immunoglobulin G (IgG) and IgM Antibodies by a Simple Recombinant Immunoblot Assay for Field Use J. Clin. Microbiol., November 1, 1998; 36(11): 3143 - 3148. [Abstract] [Full Text]